Listing 1 - 10 of 10 |
Sort by
|
Choose an application
"The oncology careforce faces challenges as population growth in the U.S. contributes to increases in the number of patients diagnosed with cancer. Significant advances in cancer research, screening and diagnostic practices, and treatment have led to the age-adjusted declining mortality rate from cancer. However, as the field continues to develop and advance, cancer care has become more complex than ever before. There is a growing concern regarding the U.S. health care system's capacity to deliver high-quality cancer care to the increasing number of patients. The National Academies convened a workshop on February 11-12, 2019 to explore trends in cancer care and identify opportunities for improvement in the rapidly developing oncology careforce. Discussions at the workshop primarily focused on trends in demographics, the careforce, and oncology practice, as well as implications for the future of cancer care and strategies to improve the organization and delivery of cancer care. Opportunities to change policy and leverage technologies in oncology were also identified. This publication summarizes the presentations and discussions from the workshop"--
Oncology --- Oncologists --- Medical Oncology --- Patient Care Team --- Personnel Management --- Quality Control --- Resilience, Psychological --- organization & administration --- United States
Choose an application
Cardiovascular system --- Oncology --- Cardiovascular Diseases --- Medical Oncology. --- Diseases --- prevention & control. --- Clinical Oncology --- Oncology, Medical --- Oncology, Clinical --- Oncology. --- Diseases. --- Tumors --- Cardiovascular diseases --- adult oncology --- amyloidosis --- basic and translational research --- genetics --- omics and tissue regeneration --- health promotion and preventive cardiology
Choose an application
Cancer --- Oncology --- Neoplasms --- Benign Neoplasms --- Malignancy --- Malignant Neoplasms --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Tumors --- Benign Neoplasm --- Cancers --- Malignancies --- Malignant Neoplasm --- Neoplasias --- Neoplasm, Benign --- Neoplasm, Malignant --- Neoplasms, Malignant --- Tumor --- Medical Oncology
Choose an application
Tumors. --- Neoplasms. --- Benign Neoplasms --- Malignancy --- Malignant Neoplasms --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Cancer --- Tumors --- Benign Neoplasm --- Cancers --- Malignancies --- Malignant Neoplasm --- Neoplasias --- Neoplasm, Benign --- Neoplasm, Malignant --- Neoplasms, Malignant --- Tumor --- Medical Oncology --- Neoplasms --- Tumours --- Pathology --- Cysts (Pathology) --- Oncology
Choose an application
Colon (Anatomy) --- Oncology --- Colorectal Neoplasms. --- Medical Oncology. --- Oncology. --- Diseases --- Diseases. --- Clinical Oncology --- Oncology, Medical --- Oncology, Clinical --- Colorectal Carcinoma --- Colorectal Tumors --- Neoplasms, Colorectal --- Colorectal Cancer --- Cancer, Colorectal --- Cancers, Colorectal --- Carcinoma, Colorectal --- Carcinomas, Colorectal --- Colorectal Cancers --- Colorectal Carcinomas --- Colorectal Neoplasm --- Colorectal Tumor --- Neoplasm, Colorectal --- Tumor, Colorectal --- Tumors, Colorectal --- Colorectum --- oncoproctology --- rectal cancer --- colon cancer --- oncology --- cancer therapy --- Tumors --- Proctology --- Intestine, Large --- Colorectal Neoplasms --- Medical Oncology --- Côlon --- Cancérologie --- Cancer colorectal. --- Cancérologie. --- Maladies
Choose an application
Oncogenes are mutated and/or overexpressed at high levels in tumor cells. Tumors of the lung, breast, pancreas, and colon may display specific oncogenetic features. These tumors have been largely associated with exposure to environmental carcinogens and a variety of biological agents, including viruses. These carcinogens can induce specific genetic and epigenetic alterations in these tissues, leading to aberrant functioning of oncogenes and tumor suppressor genes. On the microRNAs (miRNAs) there are significant modifiers of both transcription and translation of oncogenes in carcinogenesis. In the last 50 years, several oncogenes and microRNAs related to these oncogenes have been identified in different types of human cancers. It is now clear that high expression of oncogenes, DNA damage response, and regulation of the cell cycle are related to the circadian clock. This book will mainly focus on the expressions of different oncogenes in breast, colon, and lung cancers. Moreover, readers will gain qualified scientific knowledge of the alterations in miRNAs in different types of cancers and the effects of the circadian clock on the expression of oncogenes in carcinogenesis.
Oncology. --- Tumors. --- Neoplasm. --- Tumors --- Neoplasms --- Tumours --- Pathology --- Cysts (Pathology) --- Oncology --- Neoplasms. --- Benign Neoplasms --- Malignancy --- Malignant Neoplasms --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Cancer --- Benign Neoplasm --- Cancers --- Malignancies --- Malignant Neoplasm --- Neoplasias --- Neoplasm, Benign --- Neoplasm, Malignant --- Neoplasms, Malignant --- Tumor --- Medical Oncology --- Life Sciences --- Genetics and Molecular Biology --- Biochemistry --- Cancer Biology
Choose an application
Nucleic Acids. --- Neoplasms. --- Benign Neoplasms --- Malignancy --- Malignant Neoplasms --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Cancer --- Tumors --- Benign Neoplasm --- Cancers --- Malignancies --- Malignant Neoplasm --- Neoplasias --- Neoplasm, Benign --- Neoplasm, Malignant --- Neoplasms, Malignant --- Tumor --- Medical Oncology --- Acids, Nucleic --- Nucleic Acid --- Acid, Nucleic --- cancer --- oncology --- dna --- genomics --- nucleic acids --- Nucleic Acids --- Neoplasms
Choose an application
Precision medicine is rapidly becoming the standard-of-care for the treatment of cancer patients. This is made possible, in part, by the ready availability and reasonable costs of comprehensive DNA and RNA sequencing assays. However, precision medicine is complex and incorporates entirely new types of data and treatment paradigms that are outside of the training of most oncologists in practice today. Precision Medicine Oncology: A Primer is a concise review of the fundamental principles and applications of precision medicine, intended for clinicians, particularly those working in oncology. It provides an accessible introduction to the technological advances in DNA and RNA sequencing, gives a detailed overview of approaches to the interpretation of molecular test results and their point-of-care implementation for individual patients, and describes innovative clinical trial designs in oncology as well as characteristics of the computational infrastructures through which massive quantities of data are collected, stored, and used in precision medicine oncology.
Tumors --- Medical Oncology --- Precision Medicine --- Neoplasms --- Tumours --- Pathology --- Cysts (Pathology) --- Oncology --- therapy. --- Individualized medicine --- Personalized medicine --- Medical care --- Pharmacogenetics --- Medicine, oncology, precision medicine, cancer, cancer treatment, cancer patients, clinicians, medical practice, DNA, RNA, comprehensive DNA sequencing, comprehensive RNA sequencing, technological advances, molecular test results, oncologists, medical students, fellows in oncology, nurses, physician assistants, molecular tumor board, next-generation sequencing, comprehensive genomic profiling, individualized medicine.
Choose an application
oncology --- hematology --- guidelines --- recommendations --- biomarkers --- drug developments --- Hematology --- Oncology --- Neoplasms --- Benign Neoplasms --- Malignancy --- Malignant Neoplasms --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Cancer --- Tumors --- Benign Neoplasm --- Cancers --- Malignancies --- Malignant Neoplasm --- Neoplasias --- Neoplasm, Benign --- Neoplasm, Malignant --- Neoplasms, Malignant --- Tumor --- Medical Oncology --- Oncology. --- Hematology. --- Haematology --- Internal medicine --- Blood --- Diseases
Choose an application
Oncology. Neoplasms --- Pathological haematology --- Blood --- Oncology --- Neoplasms --- Hematologic Diseases --- Hematologic Neoplasms --- Oncology. --- Cancer --- Treatment --- Benign Neoplasms --- Malignancy --- Malignant Neoplasms --- Neoplasia --- Neoplasm --- Neoplasms, Benign --- Tumors --- Benign Neoplasm --- Cancers --- Malignancies --- Malignant Neoplasm --- Neoplasias --- Neoplasm, Benign --- Neoplasm, Malignant --- Neoplasms, Malignant --- Tumor --- Medical Oncology --- Body fluids --- Fear of blood --- Hematologic Malignancy --- Hematological Malignancies --- Hematological Neoplasms --- Hematopoietic Malignancies --- Malignancies, Hematologic --- Malignancy, Hematologic --- Neoplasms, Hematologic --- Neoplasms, Hematopoietic --- Hematologic Malignancies --- Hematopoietic Neoplasms --- Hematologic Neoplasm --- Hematological Malignancy --- Hematological Neoplasm --- Hematopoietic Malignancy --- Hematopoietic Neoplasm --- Malignancies, Hematological --- Malignancies, Hematopoietic --- Malignancy, Hematological --- Malignancy, Hematopoietic --- Neoplasm, Hematologic --- Neoplasm, Hematological --- Neoplasm, Hematopoietic --- Neoplasms, Hematological --- Hematological Diseases --- Blood Diseases --- Blood Disease --- Disease, Blood --- Disease, Hematologic --- Disease, Hematological --- Diseases, Blood --- Diseases, Hematologic --- Diseases, Hematological --- Hematologic Disease --- Hematological Disease --- Hematology --- Blood Cancer --- Blood Cancers --- Cancer, Blood
Listing 1 - 10 of 10 |
Sort by
|